We expect Replimune Group Inc (REPL) stock to go up on 8 June Thursday according to various data and our mathematical model.
Related News:
Replimune Group, Inc. announced the appointment of Veleka R. Peeples-Dyer to the Company’s Board of Directors effective June 1, 2023. Ms. Peeples-Dyer has served as a strategic leader at leading biopharmaceutical companies, as in-house counsel for over 16 years and as external counsel to international life science clients through her partnerships with leading life science law firms, including as Chair of the North American Food and Drug Practice and Co-Chair of the Global Regulatory Group at Baker McKenzie, a top ten international life sciences law firm. Throughout her career in the life sciences industry, including serving as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary, Veleka has provided business, legal and compliance advice and counsel on a wide variety of topics including Food and Drug Administration (FDA) regulations, global compliance, business development, clinical trials, quality, manufacturing, marketing and other corporate matters.
Ms. Peeples-Dyer currently serves on the advisory board of Syridex Bio, a life sciences impact investment firm dedicated to accelerating health equity by investing in therapies for diseases that disproportionately affect underserved populations. Ms. Peeples-Dyer holds a bachelor’s degree in political science from Hampton University and a Juris Doctorate from the University of South Carolina School of Law. Veleka is recognized as a leader in the legal and life sciences fields and has received numerous accolades, the most recent of which is being named to the Top 50 Women Leaders of DC for 2023 and being cited in the Savoy Magazine as 2022 Most Influential Black Executives in Corporate America, and 2022 Most Influential Black Lawyers.